| Company/Division name | GenBody, Inc. |
| Parent company | GenBody America, LLC |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 100 |
| Year reshoring announced: | 2022 |
| Year reshoring implemented or to be implemented: | 2022 |
| Capital investment ($): | 10 |
| Country(ies) from which reshored: | Korea, Republic of |
| City reshored to: | Jurupa Valley |
| State(s) reshored to: | CA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | antigen testing kits |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Higher productivity, Proximity to customers/market |
